Another notable point
UBS target of 1.1 billion of rev and a $26 share price or approx AUD 8 billion dollar market cap is only a rev multiple of eight.
Eli Lilly trades on a multiple of 20; being 42 billion of rev and a 840 US billion market cap
Let’s say they do 1.1 billion of rev times 20 = 22 billion market cap or approx $66 a share
Even adding no growth to the 700 mil forecast, that would put us at a 14 billion $ market cap or approx $40 a share on a 20 rev multiple
Ignoring all of the other positive irons in the fire I can’t see the thesis for being short
Short Term trading, analysis and TLX noise - No investors keep out, page-529
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.48 |
Change
0.300(1.65%) |
Mkt cap ! $6.184B | |||
| Open | High | Low | Value | Volume |
| $18.10 | $18.48 | $17.97 | $12.51M | 683.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1888 | $18.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.49 | 3946 | 4 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |